
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 1, Issue 1 45-50, Copyright © 1991 by American Association for Cancer Research
ARTICLES |
D Palli, A Decarli, F Cipriani, D Forman, D Amadori, C Avellini, A Giacosa, P Manca, A Russo and RM Salkeld
Unita di Epidemiologia, Centro per lo Studio e la Prevenzione Oncologica, Florence, Italy.
In a survey of 930 adults aged 35-74 years randomly sampled from the general population of four areas of Italy at different risks for gastric cancer (GC), plasma levels of pepsinogens (PGI and PGII) and fat-soluble vitamins were assayed. Pepsinogen levels were used to identify individuals with chronic atrophic gastritis (CAG). Severe CAG (PGI < or = 20 pg/liter) affected 5.8% of the population, but the prevalence rose with increasing age and declining social class. Severe CAG was 5 times more common in areas with high compared to low rates of GC. Risk also rose with increasing consumption of salted/dried fish but was inversely related to dietary intake of beta-carotene and to plasma retinol and cholesterol levels. The prevalence of moderate CAG (PGI > 20 pg/liter, but PGI/PGII < or = 2.9) was 6.3%. Moderate CAG was also related to age and social class and increased 1.8-fold in areas where GC rates were high, but was not strongly associated with diet or plasma nutrients. The authors discuss these findings in relation to those from a previous case-control study of GC in the same areas.
This article has been cited by other articles:
![]() |
G. Capella, G. Pera, N. Sala, A. Agudo, F. Rico, G. Del Giudicce, M. Plebani, D. Palli, H. Boeing, H B. Bueno-de-Mesquita, et al. DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study Int. J. Epidemiol., July 19, 2008; (2008) dyn145v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Weck and H. Brenner Prevalence of Chronic Atrophic Gastritis in Different Parts of the World. Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1083 - 1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kato, J. Vivas, M. Plummer, G. Lopez, S. Peraza, D. Castro, V. Sanchez, E. Cano, O. Andrade, R. Garcia, et al. Environmental Factors in Helicobacter pylori-Related Gastric Precancerous Lesions in Venezuela Cancer Epidemiol. Biomarkers Prev., March 1, 2004; 13(3): 468 - 476. [Abstract] [Full Text] |
||||
![]() |
K. Akre, L. B. Signorello, L. Engstrand, R. Bergström, S. Larsson, B. I. Eriksson, and O. Nyrén Risk for Gastric Cancer after Antibiotic Prophylaxis in Patients Undergoing Hip Replacement Cancer Res., November 1, 2000; 60(22): 6376 - 6380. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |